Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ikuo Taniguchi

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
International Heart Journal|November 16, 2006
Combined treatment with valsartan and spironolactone prevents cardiovascular remodeling in renovascular hypertensive ratsTakuya Okada, Makoto Nagai, Ikuo Taniguchi, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 22, 2003
Impaired Ca2+ handling in perfused hypertrophic hearts from Dahl salt-sensitive ratsShingo Seki, Makoto Nagai, Hiroshi Takeda, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|July 26, 2006
Effects of spironolactone during an angiotensin II receptor blocker treatment on the left ventricular mass reduction in hypertensive patients with concentric left ventricular hypertrophyIkuo Taniguchi, Makoto Kawai, Taro Date, et al.
Macromolecular Bioscience|October 7, 2004
Hydrogel formation between enantiomeric B-A-B-type block copolymers of polylactides (PLLA or PDLA: A) and polyoxyethylene (PEG: B); PEG-PLLA-PEG and PEG-PDLA-PEGTakashi Mukose, Tomoko Fujiwara, Junko Nakano, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|May 9, 2009
Telmisartan predominantly suppresses cardiac fibrosis, rather than hypertrophy, in renovascular hypertensive ratsMakoto Kawai, Kenichi Hongo, Kimiaki Komukai, et al.
International Heart Journal|November 14, 2007
The insulin sensitizer pioglitazone improves the deterioration of ischemic preconditioning in type 2 diabetes mellitus ratsHideki Sasaki, Kazuhiko Ogawa, Mitsuyuki Shimizu, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 13, 2005
Effects of bradykinin on cardiovascular remodeling in renovascular hypertensive ratsYasuyuki Tanaka, Makoto Nagai, Taro Date, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 2, 2002
Perindopril reverses myocyte remodeling in the hypertensive heartTatsuyuki Onodera, Fumiko Okazaki, Hidekazu Miyazaki, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 30, 2008
Inhibition of the renin-angiotensin system prevents re-hospitalization of heart failure patients with preserved ejection fractionKimiaki Komukai, Hidenori Yagi, Takayuki Ogawa, et al.
International Heart Journal|June 27, 2007
Mitiglinide, a novel oral hypoglycemic agent, preserves the cardioprotective effect of ischemic preconditioning in isolated perfused rat heartsKazuhiko Ogawa, Katsunori Ikewaki, Ikuo Taniguchi, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
International Heart Journal|November 16, 2006
Combined treatment with valsartan and spironolactone prevents cardiovascular remodeling in renovascular hypertensive ratsTakuya Okada, Makoto Nagai, Ikuo Taniguchi, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 22, 2003
Impaired Ca2+ handling in perfused hypertrophic hearts from Dahl salt-sensitive ratsShingo Seki, Makoto Nagai, Hiroshi Takeda, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|July 26, 2006
Effects of spironolactone during an angiotensin II receptor blocker treatment on the left ventricular mass reduction in hypertensive patients with concentric left ventricular hypertrophyIkuo Taniguchi, Makoto Kawai, Taro Date, et al.
Macromolecular Bioscience|October 7, 2004
Hydrogel formation between enantiomeric B-A-B-type block copolymers of polylactides (PLLA or PDLA: A) and polyoxyethylene (PEG: B); PEG-PLLA-PEG and PEG-PDLA-PEGTakashi Mukose, Tomoko Fujiwara, Junko Nakano, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|May 9, 2009
Telmisartan predominantly suppresses cardiac fibrosis, rather than hypertrophy, in renovascular hypertensive ratsMakoto Kawai, Kenichi Hongo, Kimiaki Komukai, et al.
International Heart Journal|November 14, 2007
The insulin sensitizer pioglitazone improves the deterioration of ischemic preconditioning in type 2 diabetes mellitus ratsHideki Sasaki, Kazuhiko Ogawa, Mitsuyuki Shimizu, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 13, 2005
Effects of bradykinin on cardiovascular remodeling in renovascular hypertensive ratsYasuyuki Tanaka, Makoto Nagai, Taro Date, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 2, 2002
Perindopril reverses myocyte remodeling in the hypertensive heartTatsuyuki Onodera, Fumiko Okazaki, Hidekazu Miyazaki, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 30, 2008
Inhibition of the renin-angiotensin system prevents re-hospitalization of heart failure patients with preserved ejection fractionKimiaki Komukai, Hidenori Yagi, Takayuki Ogawa, et al.
International Heart Journal|June 27, 2007
Mitiglinide, a novel oral hypoglycemic agent, preserves the cardioprotective effect of ischemic preconditioning in isolated perfused rat heartsKazuhiko Ogawa, Katsunori Ikewaki, Ikuo Taniguchi, et al.
Pageof 7